Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.22.2.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of computations of basic and diluted loss per share

The following table presents computations of basic and diluted loss per share for Holdings:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Cinemark Holdings, Inc.

 

$

(24.5

)

 

$

(77.8

)

 

$

(171.9

)

 

$

(428.5

)

Loss allocated to participating share-based awards (1)

 

 

0.4

 

 

 

1.5

 

 

 

2.4

 

 

 

7.6

 

Net loss attributable to common stockholders

 

$

(24.1

)

 

$

(76.3

)

 

$

(169.5

)

 

$

(420.9

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

118.4

 

 

 

117.3

 

 

 

118.1

 

 

 

117.2

 

Common equivalent shares for restricted stock units (2)

 

 

 

 

 

 

 

 

 

 

 

 

Common equivalent shares for convertible notes and warrants (3)

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

 

118.4

 

 

 

117.3

 

 

 

118.1

 

 

 

117.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per share attributable to common stockholders

 

$

(0.20

)

 

$

(0.65

)

 

$

(1.43

)

 

$

(3.59

)

Diluted loss per share attributable to common stockholders

 

$

(0.20

)

 

$

(0.65

)

 

$

(1.43

)

 

$

(3.59

)

(1)
For the three months ended September 30, 2022 and 2021, a weighted average of approximately 1.90 shares and 2.34 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2022 and 2021, a weighted average of approximately 1.69 shares and 2.11 shares of restricted stock, respectively, were considered participating securities.
(2)
For the three months ended September 30, 2022 and 2021, approximately 0.18 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. For the nine months ended September 30, 2022 and 2021, approximately 0.39 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive.
(3)
For the three and nine months ended September 30, 2022 and 2021, diluted loss per share excludes the conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as well as outstanding warrants, as they would be anti-dilutive. See further discussion below.